Stan Erck

(Mr. Stanley Erck)

Currently holds positions in BioCryst Pharmaceuticals Inc and Novavax Inc

Positions

Position Company Period
Independent Director BioCryst Pharmaceuticals Inc Dec. 22, 2008 -
President, Chief Executive Officer, Director Novavax Inc April 19, 2011 -
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-05 2024-11-01
US MaxCyte Inc (MXCT)
PS Planned sale
47,689 -15.1%
3.72
USD 177,403 		47,689 -15.1% 3.72 USD 177,403
2024-10-02 2024-10-02
US MaxCyte Inc (MXCT)
PS Planned sale
21,607 -7.4%
3.71
USD 80,162 		21,607 -7.4% 3.71 USD 80,162
2024-10-02 2024-10-01
US MaxCyte Inc (MXCT)
PS Planned sale
26,082 -8.8%
3.78
USD 98,590 		26,082 -8.8% 3.78 USD 98,590
2024-09-05 2024-09-04
US MaxCyte Inc (MXCT)
PS Planned sale
29,767 -10.0%
3.97
USD 118,175 		29,767 -10.0% 3.97 USD 118,175
2024-09-05 2024-09-03
US MaxCyte Inc (MXCT)
PS Planned sale
17,922 -6.2%
4.10
USD 73,480 		17,922 -6.2% 4.10 USD 73,480
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
500 -2.1%
180.58
USD 90,290 		500 -2.1% 180.58 USD 90,290
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
3,300 -11.9%
179.48
USD 592,282 		3,300 -11.9% 179.48 USD 592,282
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
8,563 -23.6%
178.46
USD 1,528,182 		8,563 -23.6% 178.46 USD 1,528,182
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
8,890 -19.7%
177.58
USD 1,578,724 		8,890 -19.7% 177.58 USD 1,578,724
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
4,700 -9.4%
176.48
USD 829,434 		4,700 -9.4% 176.48 USD 829,434
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
3,600 -6.7%
175.61
USD 632,198 		3,600 -6.7% 175.61 USD 632,198
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
3,100 -5.5%
174.56
USD 541,142 		3,100 -5.5% 174.56 USD 541,142
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
5,038 -8.2%
173.45
USD 873,829 		5,038 -8.2% 173.45 USD 873,829
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
3,746 -5.7%
172.36
USD 645,672 		3,746 -5.7% 172.36 USD 645,672
2021-10-05 2021-10-04
US Novavax Inc (NVAX)
PS Planned sale
1,392 -2.1%
166.98
USD 232,441 		1,392 -2.1% 166.98 USD 232,441
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
472 -1.9%
190.63
USD 89,978 		472 -1.9% 190.63 USD 89,978
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
1,502 -5.8%
189.47
USD 284,584 		1,502 -5.8% 189.47 USD 284,584
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
100 -0.4%
187.95
USD 18,795 		100 -0.4% 187.95 USD 18,795
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
8 -0.0%
185.71
USD 1,486 		8 -0.0% 185.71 USD 1,486
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
192 -0.7%
183.61
USD 35,253 		192 -0.7% 183.61 USD 35,253
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
300 -1.1%
182.40
USD 54,721 		300 -1.1% 182.40 USD 54,721
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
1,600 -5.7%
181.21
USD 289,934 		1,600 -5.7% 181.21 USD 289,934
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
2,541 -8.3%
180.42
USD 458,457 		2,541 -8.3% 180.42 USD 458,457
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
1,323 -4.1%
179.29
USD 237,200 		1,323 -4.1% 179.29 USD 237,200
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
4,604 -12.6%
178.27
USD 820,753 		4,604 -12.6% 178.27 USD 820,753
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
6,227 -14.6%
177.37
USD 1,104,474 		6,227 -14.6% 177.37 USD 1,104,474
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
2,601 -5.7%
176.24
USD 458,388 		2,601 -5.7% 176.24 USD 458,388
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
3,602 -7.4%
175.15
USD 630,878 		3,602 -7.4% 175.15 USD 630,878
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
5,853 -10.7%
174.30
USD 1,020,176 		5,853 -10.7% 174.30 USD 1,020,176
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
3,002 -5.2%
173.16
USD 519,834 		3,002 -5.2% 173.16 USD 519,834
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
4,103 -6.6%
172.02
USD 705,815 		4,103 -6.6% 172.02 USD 705,815
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
2,602 -4.0%
171.34
USD 445,814 		2,602 -4.0% 171.34 USD 445,814
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
901 -1.4%
170.07
USD 153,233 		901 -1.4% 170.07 USD 153,233
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
1,959 -2.9%
169.05
USD 331,175 		1,959 -2.9% 169.05 USD 331,175
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
2,801 -4.0%
167.88
USD 470,240 		2,801 -4.0% 167.88 USD 470,240
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
1,100 -1.5%
166.62
USD 183,286 		1,100 -1.5% 166.62 USD 183,286
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
904 -1.3%
165.68
USD 149,777 		904 -1.3% 165.68 USD 149,777
2021-10-05 2021-10-01
US Novavax Inc (NVAX)
PS Planned sale
703 -1.0%
164.74
USD 115,812 		703 -1.0% 164.74 USD 115,812
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
4,909 -19.3%
93.56
USD 459,292 		4,909 -19.3% 93.56 USD 459,292
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
17,503 -40.8%
92.97
USD 1,627,291 		17,503 -40.8% 92.97 USD 1,627,291
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
4,598 -9.7%
90.61
USD 416,638 		4,598 -9.7% 90.61 USD 416,638
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
11,234 -19.1%
89.26
USD 1,002,709 		11,234 -19.1% 89.26 USD 1,002,709
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
8,306 -12.4%
88.36
USD 733,918 		8,306 -12.4% 88.36 USD 733,918
2020-11-18 2020-11-16
US Novavax Inc (NVAX)
PS Planned sale
5,766 -7.9%
87.20
USD 502,819 		5,766 -7.9% 87.20 USD 502,819
2020-10-01 2020-10-01
US Novavax Inc (NVAX)
PS Planned sale
2 -0.0%
108.57
USD 217 		2 -0.0% 108.57 USD 217
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
100 -0.5%
115.65
USD 11,565 		100 -0.5% 115.65 USD 11,565
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
100 -0.5%
115.43
USD 11,543 		100 -0.5% 115.43 USD 11,543
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
800 -3.7%
114.73
USD 91,784 		800 -3.7% 114.73 USD 91,784
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
700 -3.2%
114.20
USD 79,940 		700 -3.2% 114.20 USD 79,940
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
800 -3.5%
112.65
USD 90,118 		800 -3.5% 112.65 USD 90,118
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
900 -3.8%
111.41
USD 100,271 		900 -3.8% 111.41 USD 100,271
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
1,676 -6.6%
110.54
USD 185,270 		1,676 -6.6% 110.54 USD 185,270
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
1,500 -5.5%
109.54
USD 164,304 		1,500 -5.5% 109.54 USD 164,304
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
5,138 -16.0%
108.56
USD 557,797 		5,138 -16.0% 108.56 USD 557,797
2020-10-01 2020-09-30
US Novavax Inc (NVAX)
PS Planned sale
517 -1.6%
107.56
USD 55,609 		517 -1.6% 107.56 USD 55,609
2016-02-01 2016-01-31
US Novavax Inc (NVAX)
PP Planned purchase
2,072 +2.1%
4.38
USD 9,075 		2,072 +2.1% 4.38 USD 9,075
// ... existing code ... // ... rest of the file ...